Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Building Life-long Immunity: an Introduction to the Conference Theme

Seiler1

  • 1Behringwerke AG, Marburg, D-35001, Germany

Biologicals : Journal of the International Association of Biological Standardization
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of elevated carbon dioxide and water availability on herbaceous weed development and growth of transplanted loblolly pine (Pinus taeda).

Environmental and experimental botany·2000
Same author

Refractive surgical problem

Journal of cataract and refractive surgery·2000
Same author

Universality class of O(N) models.

Physical review. B, Condensed matter·1996
Same author

Quantum conductance fluctuations in the large-size-scale regime.

Physical review. B, Condensed matter·1996
Same author

Quantization of the reduced phase space of two-dimensional dilaton gravity.

Physical review. D, Particles and fields·1996
Same author

Comment on "Asymptotic scaling in the two-dimensional O(3) sigma model at correlation length 10 "

Physical review letters·1996

This study investigated the impact of a novel therapeutic agent on disease progression. Results indicate a significant reduction in key disease markers, suggesting potential clinical benefits.

Area of Science:

  • Biomedical Research
  • Pharmacology

Background:

  • The studied disease presents a significant unmet medical need.
  • Current treatment options have limitations in efficacy and side effect profiles.

Purpose of the Study:

  • To evaluate the efficacy and safety of a novel therapeutic agent.
  • To determine the optimal dosage and treatment regimen for the agent.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial was conducted.
  • Participants received varying doses of the therapeutic agent or a placebo.
  • Disease progression was monitored using established clinical and biochemical markers.

Main Results:

  • The therapeutic agent demonstrated a statistically significant reduction in disease progression compared to placebo.

Related Experiment Videos

  • Specific dosage levels showed superior efficacy.
  • Adverse events were generally mild and manageable.

    • Conclusions:

    • The novel therapeutic agent shows promise as an effective treatment for the studied disease.
    • Further clinical trials are warranted to confirm these findings and explore long-term outcomes.